PDGFRB and Alzheimer disease: Moreover, postmortem vascular analysis of AD patients has identified that loss of pericytes and vascular platelet-derived growth factor receptor β (PDGFRβ) that accompany increased vascular amyloidosis in the retina, compromise the integrity of the blood retinal barrier, and provide new targets for the diagnosis and therapeutics of AD [50].